| Literature DB >> 24848576 |
Rocío Barrios1, Georgios Tsakos, Blas García-Medina, Ildefonso Martínez-Lara, Manuel Bravo.
Abstract
PURPOSE: This study examined whether oral health-related quality of life (OHRQoL) is associated with nutritional status in patients treated for oral cancer.Entities:
Mesh:
Year: 2014 PMID: 24848576 PMCID: PMC4183889 DOI: 10.1007/s00520-014-2281-5
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.603
Sample description and bivariate associations between nutritional status and socioeconomic variables in patients treated for oral cancer (n = 133)
| Variable | All | Normal | Malnutrition/Risk |
|
|---|---|---|---|---|
|
|
|
| ||
| All | 133 (100) | 103 (77.4) | 30 (22.6) | |
| Sex | 0.138a | |||
| Male | 84 (63.2) | 69 (82.1) | 15 (17.9) | |
| Female | 49 (36.8) | 34 (69.4) | 15 (30.6) | |
| Age (years) | ||||
| <55 | 29 (21.8) | 20 (69.0) | 9 (31.0) | |
| 55–64 | 34 (25.6) | 30 (88.2) | 4 (11.8) | |
| 65–74 | 36 (27.1) | 33 (91.7) | 3 (8.3) | |
| ≥75 | 34 (25.6) | 20 (58.8) | 14 (41.2) | |
| Mean ± SD | 0.234b | |||
| Social classd | 0.110c | |||
| I | 7 (5.3) | 6 (85.7) | 1 (14.3) | |
| II | 8 (6.0) | 7 (87.5) | 1 (12.5) | |
| III | 12 (9.0) | 11 (91.7) | 1 (8.3) | |
| IV | 32 (24.1) | 25 (78.1) | 7 (21.9) | |
| V | 74 (55.6) | 54 (73.0) | 20 (27.0) | |
| Tumor site | 0.815a | |||
| Tongue | 47 (35.3) | 35 (74.5) | 12 (25.5) | |
| Gingiva | 15 (11.3) | 13 (86.7) | 2 (13.3) | |
| Mouth floor | 15 (11.3) | 11 (73.3) | 4 (26.7) | |
| Oropharynx | 18 (13.5) | 15 (83.3) | 3 (16.7) | |
| Retromolar | 10 (7.5) | 8 (80.0) | 2 (20.0) | |
| Others | 28 (21.1) | 21 (75.0) | 7 (25.0) | |
| Cancer stage | 0.336c | |||
| I-II | 81 (60.9) | 65(80.2) | 16 (19.8) | |
| III-IV | 52 (39.1) | 38 (73.1) | 14 (26.9) | |
| Follow-up (years) | ||||
| 1-5 | 85 (63.9) | 64 (75.3) | 21 (24.7) | |
| 6-10 | 32 (24.1) | 27 (84.4) | 5 (15.6) | |
| 11-15 | 13 (9.8) | 11 (84.6) | 2 (15.4) | |
| 16-20 | 3 (2.3) | 1 (33.3) | 2 (66.7) | |
| Mean ± SD | 5.0 ± 4.2 | 5.0 ± 3.9 | 5.0 ± 5.2 | 0.961b |
| Functional tooth units | ||||
| Anterior (mean ± sd) | 2.3 ± 2.6 | 2.6 ± 2.7 | 1.3 ± 2.3 | 0.020b |
| Posterior (mean ± SD) | 2.4 ± 3.6 | 2.8 ± 3.8 | 1.1 ± 2.8 | 0.026b |
| Treatment | 0.715c | |||
| S | 70 (52.6) | 55 (78.6) | 15 (21.4) | |
| S + RT | 39 (29.3) | 30 (76.9) | 9 (23.1) | |
| S + RTf + CH | 24 (18.0) | 18 (75.0) | 6 (25.0) | |
S surgery, RT radiotherapy, CH chemotherapy
aChi-square test with Yates continuity correction
bStudent’s t test
cMann-Whitney test.
dIn descending order
Prevalence, overall Oral Impacts on Daily Performances (OIDP) score and extent of oral impacts in patients treated for oral cancer (n = 133)
| Statistics | Overall | Eating | Speaking | Cleaning teeth | Physical activities | Social contact | Sleeping | Smiling | Emotional status |
|---|---|---|---|---|---|---|---|---|---|
| Prevalence of oral impacts | |||||||||
| Percent | 97.0 | 83.5 | 77.4 | 14.3 | 35.3 | 35.3 | 38.3 | 24.8 | 64.7 |
| Overall OIDP score | |||||||||
| Mean (SD) | 22.4 (18.2) | 9.5 (7.2) | 7.5 (6.4) | 1.1 (3.4) | 2.3 (4.5) | 3.7 (6.0) | 2.9 (4.7) | 2.3 (5.0) | 6.4 (6.9) |
| Extent of impacts (number of performance with impacts) | |||||||||
| Affected | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| Percent | 3.0 | 12.8 | 15.8 | 19.5 | 12.8 | 8.3 | 15.0 | 10.5 | 2.3 |
Prevalence of oral impacts assessed with the Oral Health Impact Profile (OHIP-14) in patients treated for oral cancer (n = 133)
| Statistics | Overall | Functional limitation | Physical pain | Psychological discomfort | Physical disability | Mental disability | Social disability | Handicap |
|---|---|---|---|---|---|---|---|---|
| Number f oral impacts | ||||||||
| Mean ± SD | 5.8 ± 3.7 | 1.1 ± 0.7 | 1.2 ± 0.8 | 0.8 ± 0.8 | 1.0 ± 0.9 | 0.5 ± 0.8 | 0.5 ± 0.7 | 0.7 ± 0.8 |
| Extent of impacts (number of performance with impacts) | ||||||||
| Affected | 0 | 1–2 | 3–4 | 5–14 | ||||
|
| 6 (4.5) | 22 (16.6) | 31 (23.3) | 74 (55.6) | ||||
aNumber of items with score ≥2
Multiple linear regression analysis with OIDP or OHIP as dependent variable in patients treated for oral cancer (n = 133)
| Variable | OIDP | OHIP | ||
|---|---|---|---|---|
| ß-coefficient (95 % CI) |
|
|
| |
| MNA | 8.37 (1.42–15.32) | 0.019 | 2.08 (0.70-3.46) | 0.004 |
| Social class | ||||
| V vs IV | −0.05 (−7.16–7.06) | 0.989 | 0.07 (−1.35–1.48) | 0.927 |
| V vs III | −4.08 (−14.50–6.35) | 0.440 | 0.30 (−1.77–2.38) | 0.773 |
| V vs II | −5.65 (−18.13–6.84) | 0.373 | −0.45 (−2.93–2.03) | 0.720 |
| V vs I | 0.23 (−13.28–13.74) | 0.973 | −0.01 (−2.69–2.68) | 0.995 |
| Clinical stage (I–II) | 6.09 (−3.20–15.38) | 0.197 | 0.76 (−1.08–2.61) | 0.415 |
| Age (years) | −0.39 (−0.64–[-0.15]) | 0.002 | −0.07 (−0.12–[−0.02]) | 0.006 |
| Sex (male) | 12.56 (5.99–19.12) | <0.001 | 2.48 (1.19–3.79) | <0.001 |
| Follow-up (years) | −0.08 (−0.76–0.61) | 0.826 | −0.08 (−0.22–0.06) | 0.260 |
| Functional tooth | −0.67 (−1.24–[−0.10]) | 0.021 | −0.17 (−0.28–0.05) | 0.004 |
| Treatment | ||||
| S vs RT | 7.72 (−0.86–16.29) | 0.077 | 1.72 (0.01–3.43) | 0.048 |
| S vs CH | −5.86 (−17.06–5.35) | 0.303 | 0.42 (−1.80–2.65) | 0.708 |
S surgery, RT radiotherapy, CH chemotherapy